Trial · NCT01420627
Results by group171
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 171
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Patients Detoxified At Each Visit in EZN-2279 Treatment Period | EZN-2279 | Baseline | 6 | Participants | |
| Number of Patients Detoxified At Each Visit in EZN-2279 Treatment Period | EZN-2279 | Week T-1 | 6 | Participants | |
| Number of Patients Detoxified At Each Visit in EZN-2279 Treatment Period | EZN-2279 | Week T-3 | 6 | Participants | |
| Number of Patients Detoxified At Each Visit in EZN-2279 Treatment Period | EZN-2279 | Week T-5 | 5 | Participants | |
| Number of Patients Detoxified At Each Visit in EZN-2279 Treatment Period | EZN-2279 | Week T-7 | 6 | Participants | |
| Number of Patients Detoxified At Each Visit in EZN-2279 Treatment Period | EZN-2279 | Week T-8 | 6 | Participants | |
| Number of Patients Detoxified At Each Visit in EZN-2279 Treatment Period | EZN-2279 | Week T-9 | 3 | Participants | |
| Number of Patients Detoxified At Each Visit in EZN-2279 Treatment Period | EZN-2279 | Week T-10 | 5 | Participants | |
| Number of Patients Detoxified At Each Visit in EZN-2279 Treatment Period | EZN-2279 | Week T-11 | 6 | Participants | |
| Number of Patients Detoxified At Each Visit in EZN-2279 Treatment Period | EZN-2279 | Week T-13 | 6 | Participants | |
| Number of Patients Detoxified At Each Visit in EZN-2279 Treatment Period | EZN-2279 | Week T-15 | 6 | Participants | |
| Number of Patients Detoxified At Each Visit in EZN-2279 Treatment Period | EZN-2279 | Week T-17 | 6 | Participants | |
| Number of Patients Detoxified At Each Visit in EZN-2279 Treatment Period | EZN-2279 | Week T-19 | 6 | Participants | |
| Number of Patients Detoxified At Each Visit in EZN-2279 Treatment Period | EZN-2279 | Week T-21 | 6 | Participants | |
| Safety Summary Data | Adagen | Patients with treatment-emergent adverse events | 6 | Participants | |
| Safety Summary Data | EZN-2279 | Patients with treatment-emergent adverse events | 7 | Participants | |
| Safety Summary Data | Adagen | Mild TEAE | 4 | Participants | |
| Safety Summary Data | EZN-2279 | Mild TEAE | 1 | Participants | |
| Safety Summary Data | Adagen | Moderate TEAE | 2 | Participants | |
| Safety Summary Data | EZN-2279 | Moderate TEAE | 3 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01420627/results